All Stories

  1. Long-term results of the AIEOP MH’96 childhood Hodgkin’s lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy
  2. Fungal infection still represents a major threat for hematological patients
  3. Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use
  4. review of data on filgrastim and biosimilar G-CSF
  5. Voriconazole in clinical practice
  6. Epidemiology, risk factors, and therapy of candidemia in pediatric hematological patients
  7. Hyperbaric oxygen treatment of superficial soft tissue lesions in children with oncologic disease
  8. Prophylaxis and therapy of viral infections in pediatric patients treated for malignancy
  9. Current evidence of antifungal prophylaxis and therapy in pediatric patients
  10. Severe liver toxicity after chemotherapy for Wilms Tumor
  11. Central Venous Catheter Flushing and an Outbreak of Bacteremia among Pediatric Hematology-Oncology Patients
  12. Does granulocyte transfusion play a role in the multidisciplinary treatment of invasive mycosis?
  13. Rituximab and factors predictive of response in chronic immune thrombocytopenic purpura of children
  14. Which immunization for children after chemotherapy?
  15. Combination Antifungal Therapy for Invasive Aspergillosis
  16. Author reply
  17. Peripherally inserted central venous catheter in pediatric hematological patients
  18. Del 22Q11.2 and hemophagocytic lymphohistiocytosis: A non-random association
  19. Palliative and terminal care for dying children; proposals for better care
  20. Chronic hepatitis B surface antigen-negative hepatitis after treatment of malignancy